These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6279842)

  • 1. Synthesis and enzymic activity of various substituted pyrazolo[1,5-a]-1,3,5-triazines as adenosine cyclic 3',5'-phosphate phosphodiesterase inhibitors.
    Senga K; O'Brien DE; Scholten MB; Novinson T; Miller JP; Robins RK
    J Med Chem; 1982 Mar; 25(3):243-9. PubMed ID: 6279842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and enzymic activity of 6-carbethoxy- and 6-ethoxy-3,7-disubstituted-pyrazolo[1,5-a]pyrimidines and related derivatives as adenosine cyclic 3' ,5'-phosphate phosphodiesterase inhibitors.
    Springer RH; Scholten MB; O'Brien DE; Novinson T; Miller JP; Robins RK
    J Med Chem; 1982 Mar; 25(3):235-42. PubMed ID: 6279841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine cyclic 3',5',-monophosphate phosphodiesterasr inhibitors. 2.3-Substituted 5,7-dialkylpyrazolo [1,5-a]pyrimidines.
    Novinson T; Miller JP; Scholten M; Robins RK; Simon LN; O'Brien DE; Meyer RB
    J Med Chem; 1975 May; 18(5):460-4. PubMed ID: 168380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives.
    Leroux F; van Keulen BJ; Daliers J; Pommery N; Hénichart JP
    Bioorg Med Chem; 1999 Mar; 7(3):509-16. PubMed ID: 10220036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of rat heart and brain cyclic adenosine-3',5'-monophosphate phosphodiesterase in vitro under the influence of neurohormone C].
    Galoian AA; Gurvits BIa; Pogosian MA
    Biull Eksp Biol Med; 1977 Jun; 83(6):691-3. PubMed ID: 195650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Substituted derivatives of adenosine 3',5'-cyclic phosphate require an unsubstituted 2'-hydroxyl group in the ribo configuration for biological activity.
    Khwaja TA; Boswell KH; Robins RK; Miller JP
    Biochemistry; 1975 Sep; 14(19):4238-44. PubMed ID: 170958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents.
    Novinson T; Springer RH; O'Brien DE; Scholten MB; Miller JP; Robins RK
    J Med Chem; 1982 Apr; 25(4):420-6. PubMed ID: 6279846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues.
    Marivet MC; Bourguignon JJ; Lugnier C; Mann A; Stoclet JC; Wermuth CG
    J Med Chem; 1989 Jul; 32(7):1450-7. PubMed ID: 2544722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
    Tateson JE; Trist DG
    Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    Endoh M; Satoh K; Yamashita S
    Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative structure-activity relationships for the inhibition of heart and brain cyclic AMP phosphodiesterases by some phenylbutenolides.
    Duperray B; Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1980 Jan; 29(1):115-8. PubMed ID: 6244825
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase.
    Pericin D; Leskovac V
    Arzneimittelforschung; 1981; 31(12):2082-5. PubMed ID: 6277342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of [N-(2-oxo-3,5,7-cycloheptatrien-1-yl)] aminooxoacetic acid ethyl ester (AY-25,674) on cyclic 3',5'-nucleotide formation and phosphodiesterase activity.
    Pugsley TA; Lippmann W
    Experientia; 1979 Jan; 35(1):88-90. PubMed ID: 217716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of base-substituted and carboxyl-esterified analogues of griseolic acid, a potent cAMP phosphodiesterase inhibitor.
    Yasumoto T; Iijima Y; Kaneko M; Yamazaki M
    Biochem Pharmacol; 1992 May; 43(10):2073-81. PubMed ID: 1318049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
    Konno S; Kokubo T; Amano M; Yoshida N; Sagi M; Yamanaka H
    Yakugaku Zasshi; 1992 Oct; 112(10):729-41. PubMed ID: 1469603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-substituted derivatives of adenosine and inosine cyclic 3',5'-phosphate. Synthesis, enzymic activity, and analysis of the structural requirements of the binding locale of the 2-substituent on bovine brain protein kinase.
    Meyer RB; Uno H; Robins RK; Simon LN; Miller JP
    Biochemistry; 1975 Jul; 14(15):3315-21. PubMed ID: 167824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
    Galoian AA; Gurvits BIa; Pogosian MA
    Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
    Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.